Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,167,727
  • Shares Outstanding, K 29,058
  • Annual Sales, $ 166,030 K
  • Annual Income, $ -84,600 K
  • EBIT $ -54 M
  • EBITDA $ -46 M
  • 60-Month Beta 0.99
  • Price/Sales 11.55
  • Price/Cash Flow N/A
  • Price/Book 130.20

Options Overview Details

View History
  • Implied Volatility 76.70% (-4.79%)
  • Historical Volatility 52.50%
  • IV Percentile 67%
  • IV Rank 38.02%
  • IV High 123.47% on 04/08/25
  • IV Low 48.01% on 06/12/25
  • Expected Move (DTE 4) 7.79 (10.44%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 67
  • Volume Avg (30-Day) 552
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 42,362
  • Open Int (30-Day) 41,420
  • Expected Range 66.81 to 82.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.27
  • Prior Year -0.98
  • Growth Rate Est. (year over year) +77.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.00 +18.41%
on 01/27/26
75.70 -1.45%
on 02/13/26
+9.47 (+14.54%)
since 01/13/26
3-Month
61.85 +20.61%
on 11/18/25
78.24 -4.65%
on 12/17/25
+9.85 (+15.21%)
since 11/13/25
52-Week
26.56 +180.87%
on 04/09/25
78.24 -4.65%
on 12/17/25
+41.01 (+122.09%)
since 02/13/25

Most Recent Stories

More News
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 74.60 (+1.44%)
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Revenue for the quarter ended December 31, 2025 is expected to be between $64.0 million and $65.0 million, including between $17.0 million and $17.5 million from Motiva sales in the United States. ...

ESTA : 74.60 (+1.44%)
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.60 (+1.44%)
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.60 (+1.44%)
Establishment Labs to Present at Jefferies London Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.60 (+1.44%)
Establishment Labs Reports Third Quarter 2025 Financial Results

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.60 (+1.44%)
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 74.60 (+1.44%)
Canaccord Genuity Keeps Their Buy Rating on Establishment Labs Holdings (ESTA)

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on Establishment Labs Holdings, with a price target of $60.00. The company’s shares closed yesterday at $44.40.Elevate...

ESTA : 74.60 (+1.44%)
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the...

ESTA : 74.60 (+1.44%)
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced...

ESTA : 74.60 (+1.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its...

See More

Key Turning Points

3rd Resistance Point 79.57
2nd Resistance Point 77.63
1st Resistance Point 76.12
Last Price 74.60
1st Support Level 72.67
2nd Support Level 70.73
3rd Support Level 69.22

See More

52-Week High 78.24
Last Price 74.60
Fibonacci 61.8% 58.50
Fibonacci 50% 52.40
Fibonacci 38.2% 46.30
52-Week Low 26.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar